Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-13,554
Closed -$190K 24
2016
Q1
$190K Sell
13,554
-456,989
-97% -$4.89M 0.22% 13
2015
Q4
$4.8M Hold
470,543
4.56% 7
2015
Q3
$7.72M Buy
470,543
+73,645
+19% +$1.17M 7.18% 5
2015
Q2
$9.37M Buy
396,898
+25,457
+7% +$625K 12.87% 3
2015
Q1
$9.14M Buy
371,441
+22,195
+6% +$617K 4.23% 9
2014
Q4
$10.1M Sell
349,246
-143,209
-29% -$4.66M 4.82% 8
2014
Q3
$19M Hold
492,455
4.94% 6
2014
Q2
$26.2M Buy
492,455
+62,708
+15% +$3.22M 6.25% 3
2014
Q1
$25.5M Buy
429,747
+132,431
+45% +$9.42M 6.14% 4
2013
Q4
$27M Buy
297,316
+62,828
+27% +$6.07M 6.05% 4
2013
Q3
$21.8M Sell
234,488
-757
-0.3% -$94.5K 3.72% 3
2013
Q2
$29.6M Buy
+235,245
New +$30.4M 5.68% 1

Other funds holding VVUS

Tahithromos's VVUS Position: Q2 2016 in Review

Tahithromos sold out of Vivus Inc (VVUS) in Q2 2016, closing a stake of 13,554 shares — an estimated $190K sold.

Tahithromos first reported a position in VVUS in Q2 2013 and held it in 12 quarters. The position peaked at $29.6M in Q2 2013. 84 funds tracked by Wall St. Rank hold VVUS as of Q2 2016.

  • Tahithromos reported no remaining Vivus Inc position as of Q2 2016 after selling out during the quarter.
  • Tahithromos sold 13,554 Vivus Inc shares in Q2 2016, an estimated $190K.
  • Tahithromos first reported a position in Vivus Inc in Q2 2013 and held it in 12 quarters.
  • Tahithromos's Vivus Inc position peaked at $29.6M in Q2 2013.
  • 84 funds tracked by Wall St. Rank held Vivus Inc as of Q2 2016.

Based on Tahithromos's 13F filing for Q2 2016, filed 28 Jul 2016.